$100M financing to advance immuno-dermatology pipeline
Alys Pharmaceuticals has launched with an R&D pipeline enabled by multiple platform technologies and a $100 million financing by Medicxi. The company originates from the aggregation of six Medicxi companies. Co-founded by Medicxi and several dermatology and scientific experts, including John Harris (UMass Chan Medical School), Brian… Read More